KIT and gastrointestinal stromal tumor: Of note, based on MTS-based cytotoxicity data, as shown in Table 1, we chose the subtoxic concentration of IM (0.02 μM) for IM-naive GIST T-1 cells to examine whether the inhibition of KIT signaling in GIST affects the production of VEGF-A regardless of the cellular viability.